Chiral compounds in which biological activity resides in only one of the enantiomers are, increasingly, being demanded in enantiomerically pure form. The use of biocatalysts for production of epoxides as chiral intermediates in the synthesis of these compounds has realistic commercial prospects, but also presents formidable technical problems.
|Number of pages||6|
|Journal||Trends in Biotechnology|
|Publication status||Published - 1 Jan 1992|
ASJC Scopus subject areas